Localization and sub-cellular shuttling of HTLV-1 tax with the miRNA machinery

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  van Duyne, Rachel ^a,b   Guendel, Irene ^a   Klase, Zachary ^c   Narayanan, Aarthi ^a   Coley, William ^b   Jaworski, Elizabeth ^a   Roman, Jessica ^a   Popratiloff, Anastas ^d   Mahieux, Renaud ^e   Kehn Hall, Kylene ^a   Kashanchi, Fatah ^a,b  

^a GEORGE MASON UNIVERSITY   (United States)

^b GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d GEORGE WASHINGTON UNIVERSITY   (United States)

^e CENTRE INTERNATIONAL DE RECHERCHE EN INFECTIOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DROSHA PROTEIN; MICRORNA; PROTEASOME; PROTEASOME INHIBITOR; TAX PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA;

ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNOPRECIPITATION; IN VITRO STUDY; NONHUMAN; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RNA CLEAVAGE; RNA INTERFERENCE; VIRUS CELL INTERACTION;

CELL NUCLEUS; DOWN-REGULATION; GENE PRODUCTS, TAX; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; MICRORNAS; PROTEIN BINDING; PROTEIN TRANSPORT; PROTEINS; RIBONUCLEASE III; RNA INTERFERENCE; SUBCELLULAR FRACTIONS; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 84863661535     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040662     Document Type: Article

References (96)

1. Easley R, van Duyne R, Coley W, Guendel I, Dadgar S, et al. (2010) Chromatin dynamics associated with HIV-1 Tat-activated transcription. Biochim Biophys Acta 1799: 275-285.
2. Gallo RC, (2005) History of the discoveries of the first human retroviruses: HTLV-1 and HTLV-2. Oncogene 24: 5926-5930.
3. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, et al. (1980) Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A 77: 7415-7419.
4. Poiesz BJ, Ruscetti FW, Mier JW, Woods AM, Gallo RC, (1980) T-cell lines established from human T-lymphocytic neoplasias by direct response to T-cell growth factor. Proc Natl Acad Sci U S A 77: 6815-6819.
5. Yin MJ, Christerson LB, Yamamoto Y, Kwak YT, Xu S, et al. (1998) HTLV-I Tax protein binds to MEKK1 to stimulate IkappaB kinase activity and NF-kappaB activation. Cell 93: 875-884.
6. Grassmann R, Aboud M, Jeang KT, (2005) Molecular mechanisms of cellular transformation by HTLV-1 Tax. Oncogene 24: 5976-5985.
7. Semmes OJ, Jeang KT, (1996) Localization of human T-cell leukemia virus type 1 tax to subnuclear compartments that overlap with interchromatin speckles. J Virol 70: 6347-6357.
8. Taylor JM, Nicot C, (2008) HTLV-1 and apoptosis: role in cellular transformation and recent advances in therapeutic approaches. Apoptosis 13: 733-747.
9. Nelson P, Kiriakidou M, Sharma A, Maniataki E, Mourelatos Z, (2003) The microRNA world: small is mighty. Trends Biochem Sci 28: 534-540.
10. Kim VN, Han J, Siomi MC, (2009) Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 10: 126-139.
11. Houzet L, Jeang KT, (2011) MicroRNAs and human retroviruses. Biochim Biophys Acta 1809: 686-693.
12. Haasnoot J, de Vries W, Geutjes EJ, Prins M, de Haan P, et al. (2007) The Ebola virus VP35 protein is a suppressor of RNA silencing. PLoS Pathog 3: e86.
13. Wang Y, Kato N, Jazag A, Dharel N, Otsuka M, et al. (2006) Hepatitis C virus core protein is a potent inhibitor of RNA silencing-based antiviral response. Gastroenterology 130: 883-892.
14. Bennasser Y, Le SY, Benkirane M, Jeang KT, (2005) Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity 22: 607-619.
15. Abe M, Suzuki H, Nishitsuji H, Shida H, Takaku H, (2010) Interaction of human T-cell lymphotropic virus type I Rex protein with Dicer suppresses RNAi silencing. FEBS Lett 584: 4313-4318.
16. Lu S, Cullen BR, (2004) Adenovirus VA1 noncoding RNA can inhibit small interfering RNA and MicroRNA biogenesis. J Virol 78: 12868-12876.
17. Lecellier CH, Dunoyer P, Arar K, Lehmann-Che J, Eyquem S, et al. (2005) A cellular microRNA mediates antiviral defense in human cells. Science 308: 557-560.
18. Delgadillo MO, Saenz P, Salvador B, Garcia JA, Simon-Mateo C, (2004) Human influenza virus NS1 protein enhances viral pathogenicity and acts as an RNA silencing suppressor in plants. J Gen Virol 85: 993-999.
19. Qian S, Zhong X, Yu L, Ding B, de Haan P, et al. (2009) HIV-1 Tat RNA silencing suppressor activity is conserved across kingdoms and counteracts translational repression of HIV-1. Proc Natl Acad Sci U S A 106: 605-610.
20. Schnettler E, de Vries W, Hemmes H, Haasnoot J, Kormelink R, et al. (2009) The NS3 protein of rice hoja blanca virus complements the RNAi suppressor function of HIV-1 Tat. EMBO Rep 10: 258-263.
21. de Vries W, Haasnoot J, Fouchier R, de Haan P, Berkhout B, (2009) Differential RNA silencing suppression activity of NS1 proteins from different influenza A virus strains. J Gen Virol 90: 1916-1922.
22. Bennasser Y, Yeung ML, Jeang KT, (2006) HIV-1 TAR RNA subverts RNA interference in transfected cells through sequestration of TAR RNA-binding protein, TRBP. J Biol Chem 281: 27674-27678.
23. Fabozzi G, Nabel CS, Dolan MA, Sullivan NJ, (2011) Ebolavirus proteins suppress the effects of small interfering RNA by direct interaction with the mammalian RNA interference pathway. J Virol 85: 2512-2523.
24. Karjee S, Minhas A, Sood V, Ponia SS, Banerjea AC, et al. (2010) The 7a accessory protein of severe acute respiratory syndrome coronavirus acts as an RNA silencing suppressor. J Virol 84: 10395-10401.
25. Ji J, Glaser A, Wernli M, Berke JM, Moradpour D, et al. (2008) Suppression of short interfering RNA-mediated gene silencing by the structural proteins of hepatitis C virus. J Gen Virol 89: 2761-2766.
26. Soldan SS, Plassmeyer ML, Matukonis MK, Gonzalez-Scarano F, (2005) La Crosse virus nonstructural protein NSs counteracts the effects of short interfering RNA. J Virol 79: 234-244.
27. Li WX, Li H, Lu R, Li F, Dus M, et al. (2004) Interferon antagonist proteins of influenza and vaccinia viruses are suppressors of RNA silencing. Proc Natl Acad Sci U S A 101: 1350-1355.
28. Haller K, Wu Y, Derow E, Schmitt I, Jeang KT, et al. (2002) Physical interaction of human T-cell leukemia virus type 1 Tax with cyclin-dependent kinase 4 stimulates the phosphorylation of retinoblastoma protein. Mol Cell Biol 22: 3327-3338.
29. Jin DY, Spencer F, Jeang KT, (1998) Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1. Cell 93: 81-91.
30. Suzuki T, Hirai H, Yoshida M, (1994) Tax protein of HTLV-1 interacts with the Rel homology domain of NF-kappa B p65 and c-Rel proteins bound to the NF-kappa B binding site and activates transcription. Oncogene 9: 3099-3105.
31. Caron C, Rousset R, Beraud C, Moncollin V, Egly JM, et al. (1993) Functional and biochemical interaction of the HTLV-I Tax1 transactivator with TBP. EMBO J 12: 4269-4278.
32. Clemens KE, Piras G, Radonovich MF, Choi KS, Duvall JF, et al. (1996) Interaction of the human T-cell lymphotropic virus type 1 tax transactivator with transcription factor IIA. Mol Cell Biol 16: 4656-4664.
33. Colgin MA, Nyborg JK, (1998) The human T-cell leukemia virus type 1 oncoprotein Tax inhibits the transcriptional activity of c-Myb through competition for the CREB binding protein. J Virol 72: 9396-9399.
34. Gachon F, Thebault S, Peleraux A, Devaux C, Mesnard JM, (2000) Molecular interactions involved in the transactivation of the human T-cell leukemia virus type 1 promoter mediated by Tax and CREB-2 (ATF-4). Mol Cell Biol 20: 3470-3481.
35. Harrod R, Tang Y, Nicot C, Lu HS, Vassilev A, et al. (1998) An exposed KID-like domain in human T-cell lymphotropic virus type 1 Tax is responsible for the recruitment of coactivators CBP/p300. Mol Cell Biol 18: 5052-5061.
36. Kashanchi F, Brady JN, (2005) Transcriptional and post-transcriptional gene regulation of HTLV-1. Oncogene 24: 5938-5951.
37. Kashanchi F, Duvall JF, Kwok RP, Lundblad JR, Goodman RH, et al. (1998) The coactivator CBP stimulates human T-cell lymphotrophic virus type I Tax transactivation in vitro. J Biol Chem 273: 34646-34652.
38. Nicot C, Mahieux R, Opavsky R, Cereseto A, Wolff L, et al. (2000) HTLV-I Tax transrepresses the human c-Myb promoter independently of its interaction with CBP or p300. Oncogene 19: 2155-2164.
39. Xiao G, Cvijic ME, Fong A, Harhaj EW, Uhlik MT, et al. (2001) Retroviral oncoprotein Tax induces processing of NF-kappaB2/p100 in T cells: evidence for the involvement of IKKalpha. EMBO J 20: 6805-6815.
40. Yin MJ, Paulssen EJ, Seeler JS, Gaynor RB, (1995) Protein domains involved in both in vivo and in vitro interactions between human T-cell leukemia virus type I tax and CREB. J Virol 69: 3420-3432.
41. Yamaoka S, Courtois G, Bessia C, Whiteside ST, Weil R, et al. (1998) Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell 93: 1231-1240.
42. Suzuki T, Kitao S, Matsushime H, Yoshida M, (1996) HTLV-1 Tax protein interacts with cyclin-dependent kinase inhibitor p16INK4A and counteracts its inhibitory activity towards CDK4. EMBO J 15: 1607-1614.
43. Jeong SJ, Radonovich M, Brady JN, Pise-Masison CA, (2004) HTLV-I Tax induces a novel interaction between p65/RelA and p53 that results in inhibition of p53 transcriptional activity. Blood 104: 1490-1497.
44. Giebler HA, Loring JE, van Orden K, Colgin MA, Garrus JE, et al. (1997) Anchoring of CREB binding protein to the human T-cell leukemia virus type 1 promoter: a molecular mechanism of Tax transactivation. Mol Cell Biol 17: 5156-5164.
45. Kwok RP, Laurance ME, Lundblad JR, Goldman PS, Shih H, et al. (1996) Control of cAMP-regulated enhancers by the viral transactivator Tax through CREB and the co-activator CBP. Nature 380: 642-646.
46. Wu K, Bottazzi ME, de la Fuente C, Deng L, Gitlin SD, et al. (2004) Protein profile of tax-associated complexes. J Biol Chem 279: 495-508.
47. Kehn K, Fuente Cde L, Strouss K, Berro R, Jiang H, et al. (2005) The HTLV-I Tax oncoprotein targets the retinoblastoma protein for proteasomal degradation. Oncogene 24: 525-540.
48. Rahman S, Quann K, Pandya D, Singh S, Khan ZK, et al. (2012) HTLV-1 Tax mediated downregulation of miRNAs associated with chromatin remodeling factors in T cells with stably integrated viral promoter. PLoS One 7: e34490.
49. Zheng ZM, (2010) Viral oncogenes, noncoding RNAs, and RNA splicing in human tumor viruses. Int J Biol Sci 6: 730-755.
50. Coley W, van Duyne R, Carpio L, Guendel I, Kehn-Hall K, et al. (2010) Absence of DICER in monocytes and its regulation by HIV-1. J Biol Chem 285: 31930-31943.
51. Robek MD, Ratner L, (1999) Immortalization of CD4(+) and CD8(+) T lymphocytes by human T-cell leukemia virus type 1 Tax mutants expressed in a functional molecular clone. J Virol 73: 4856-4865.
52. Lee WR, Yu XF, Syu WJ, Essex M, Lee TH, (1992) Mutational analysis of conserved N-linked glycosylation sites of human immunodeficiency virus type 1 gp41. J Virol 66: 1799-1803.
53. Smith MR, Greene WC, (1990) Identification of HTLV-I tax trans-activator mutants exhibiting novel transcriptional phenotypes. Genes Dev 4: 1875-1885.
54. Yamaoka S, Inoue H, Sakurai M, Sugiyama T, Hazama M, et al. (1996) Constitutive activation of NF-kappa B is essential for transformation of rat fibroblasts by the human T-cell leukemia virus type I Tax protein. EMBO J 15: 873-887.
55. Goren I, Semmes OJ, Jeang KT, Moelling K, (1995) The amino terminus of Tax is required for interaction with the cyclic AMP response element binding protein. J Virol 69: 5806-5811.
56. Harrod R, Kuo YL, Tang Y, Yao Y, Vassilev A, et al. (2000) p300 and p300/cAMP-responsive element-binding protein associated factor interact with human T-cell lymphotropic virus type-1 Tax in a multi-histone acetyltransferase/activator-enhancer complex. J Biol Chem 275: 11852-11857.
57. Smith MR, Greene WC, (1992) Characterization of a novel nuclear localization signal in the HTLV-I tax transactivator protein. Virology 187: 316-320.
58. Xiao G, Sun SC, (2000) Activation of IKKalpha and IKKbeta through their fusion with HTLV-I tax protein. Oncogene 19: 5198-5203.
59. Basbous J, Bazarbachi A, Granier C, Devaux C, Mesnard JM, (2003) The central region of human T-cell leukemia virus type 1 Tax protein contains distinct domains involved in subunit dimerization. J Virol 77: 13028-13035.
60. Gatza ML, Marriott SJ, (2006) Genotoxic stress and cellular stress alter the subcellular distribution of human T-cell leukemia virus type 1 tax through a CRM1-dependent mechanism. J Virol 80: 6657-6668.
61. Fu DX, Kuo YL, Liu BY, Jeang KT, Giam CZ, (2003) Human T-lymphotropic virus type I tax activates I-kappa B kinase by inhibiting I-kappa B kinase-associated serine/threonine protein phosphatase 2A. J Biol Chem 278: 1487-1493.
62. Semmes OJ, Jeang KT, (1995) Definition of a minimal activation domain in human T-cell leukemia virus type I Tax. J Virol 69: 1827-1833.
63. Alefantis T, Jain P, Ahuja J, Mostoller K, Wigdahl B, (2005) HTLV-1 Tax nucleocytoplasmic shuttling, interaction with the secretory pathway, extracellular signaling, and implications for neurologic disease. J Biomed Sci 12: 961-974.
64. Rousset R, Fabre S, Desbois C, Bantignies F, Jalinot P, (1998) The C-terminus of the HTLV-1 Tax oncoprotein mediates interaction with the PDZ domain of cellular proteins. Oncogene 16: 643-654.
65. Chiari E, Lamsoul I, Lodewick J, Chopin C, Bex F, et al. (2004) Stable ubiquitination of human T-cell leukemia virus type 1 tax is required for proteasome binding. J Virol 78: 11823-11832.
66. Watashi K, Yeung ML, Starost MF, Hosmane RS, Jeang KT, (2010) Identification of small molecules that suppress microRNA function and reverse tumorigenesis. J Biol Chem 285: 24707-24716.
67. Ruggero K, Corradin A, Zanovello P, Amadori A, Bronte V, et al. (2010) Role of microRNAs in HTLV-1 infection and transformation. Mol Aspects Med 31: 367-382.
68. Yoshida K, Seo Y, Yamasaki H, Tanoue K, Murakoshi N, et al. (2007) Effect of triangle ventricular pacing on haemodynamics and dyssynchrony in patients with advanced heart failure: a comparison study with conventional bi-ventricular pacing therapy. Eur Heart J 28: 2610-2619.
69. Jiang H, Lu H, Schiltz RL, Pise-Masison CA, Ogryzko VV, et al. (1999) PCAF interacts with tax and stimulates tax transactivation in a histone acetyltransferase-independent manner. Mol Cell Biol 19: 8136-8145.
70. Lemasson I, Polakowski NJ, Laybourn PJ, Nyborg JK, (2004) Transcription regulatory complexes bind the human T-cell leukemia virus 5′ and 3′ long terminal repeats to control gene expression. Mol Cell Biol 24: 6117-6126.
71. Lenzmeier BA, Giebler HA, Nyborg JK, (1998) Human T-cell leukemia virus type 1 Tax requires direct access to DNA for recruitment of CREB binding protein to the viral promoter. Mol Cell Biol 18: 721-731.
72. Xia T, O'Hara A, Araujo I, Barreto J, Carvalho E, et al. (2008) EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3. Cancer Res 68: 1436-1442.
73. Barth S, Pfuhl T, Mamiani A, Ehses C, Roemer K, et al. (2008) Epstein-Barr virus-encoded microRNA miR-BART2 down-regulates the viral DNA polymerase BALF5. Nucleic Acids Res 36: 666-675.
74. Choy EY, Siu KL, Kok KH, Lung RW, Tsang CM, et al. (2008) An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival. J Exp Med 205: 2551-2560.
75. Lo AK, To KF, Lo KW, Lung RW, Hui JW, et al. (2007) Modulation of LMP1 protein expression by EBV-encoded microRNAs. Proc Natl Acad Sci U S A 104: 16164-16169.
76. Strebel K, Luban J, Jeang KT, (2009) Human cellular restriction factors that target HIV-1 replication. BMC Med 7: 48.
77. Bennasser Y, Jeang KT, (2006) HIV-1 Tat interaction with Dicer: requirement for RNA. Retrovirology 3: 95.
78. Bennasser Y, Le SY, Yeung ML, Jeang KT, (2006) MicroRNAs in human immunodeficiency virus-1 infection. Methods Mol Biol 342: 241-253.
79. Bennasser Y, Yeung ML, Benkirane M, Jeang KT, (2006) RNA interference and HIV-1: hits and misses. Curr Opin HIV AIDS 1: 208-211.
80. Haasnoot J, Westerhout EM, Berkhout B, (2007) RNA interference against viruses: strike and counterstrike. Nat Biotechnol 25: 1435-1443.
81. Ballaun C, Farrington GK, Dobrovnik M, Rusche J, Hauber J, et al. (1991) Functional analysis of human T-cell leukemia virus type I rex-response element: direct RNA binding of Rex protein correlates with in vivo activity. J Virol 65: 4408-4413.
82. Kusuhara K, Anderson M, Pettiford SM, Green PL, (1999) Human T-cell leukemia virus type 2 Rex protein increases stability and promotes nuclear to cytoplasmic transport of gag/pol and env RNAs. J Virol 73: 8112-8119.
83. Narayan M, Kusuhara K, Green PL, (2001) Phosphorylation of two serine residues regulates human T-cell leukemia virus type 2 Rex function. J Virol 75: 8440-8448.
84. Satou Y, Nosaka K, Koya Y, Yasunaga JI, Toyokuni S, et al. (2004) Proteasome inhibitor, bortezomib, potently inhibits the growth of adult T-cell leukemia cells both in vivo and in vitro. Leukemia 18: 1357-1363.
85. Mitra-Kaushik S, Harding JC, Hess JL, Ratner L, (2004) Effects of the proteasome inhibitor PS-341 on tumor growth in HTLV-1 Tax transgenic mice and Tax tumor transplants. Blood 104: 802-809.
86. Abou-Merhi R, Khoriaty R, Arnoult D, El Hajj H, Dbouk H, et al. (2007) PS-341 or a combination of arsenic trioxide and interferon-alpha inhibit growth and induce caspase-dependent apoptosis in KSHV/HHV-8-infected primary effusion lymphoma cells. Leukemia 21: 1792-1801.
87. Nasr R, El-Sabban ME, Karam JA, Dbaibo G, Kfoury Y, et al. (2005) Efficacy and mechanism of action of the proteasome inhibitor PS-341 in T-cell lymphomas and HTLV-I associated adult T-cell leukemia/lymphoma. Oncogene 24: 419-430.
88. Chowdhury IH, Radonovich M, Mahieux R, Pise-Masison C, Muralidhar S, et al. (2003) P53 facilitates degradation of human T-cell leukaemia virus type I Tax-binding protein through a proteasome-dependent pathway. J Gen Virol 84: 897-906.
89. Bellon M, Lepelletier Y, Hermine O, Nicot C, (2009) Deregulation of microRNA involved in hematopoiesis and the immune response in HTLV-I adult T-cell leukemia. Blood 113: 4914-4917.
90. Pichler K, Schneider G, Grassmann R, (2008) MicroRNA miR-146a and further oncogenesis-related cellular microRNAs are dysregulated in HTLV-1-transformed T lymphocytes. Retrovirology 5: 100.
91. Houzet L, Yeung ML, de Lame V, Desai D, Smith SM, et al. (2008) MicroRNA profile changes in human immunodeficiency virus type 1 (HIV-1) seropositive individuals. Retrovirology 5: 118.
92. Yeung ML, Bennasser Y, Watashi K, Le SY, Houzet L, et al. (2009) Pyrosequencing of small non-coding RNAs in HIV-1 infected cells: evidence for the processing of a viral-cellular double-stranded RNA hybrid. Nucleic Acids Res 37: 6575-6586.
93. Chen R, Alvero AB, Silasi DA, Kelly MG, Fest S, et al. (2008) Regulation of IKKbeta by miR-199a affects NF-kappaB activity in ovarian cancer cells. Oncogene 27: 4712-4723.
94. Sakurai K, Furukawa C, Haraguchi T, Inada K, Shiogama K, et al. (2011) MicroRNAs miR-199a-5p and-3p target the Brm subunit of SWI/SNF to generate a double-negative feedback loop in a variety of human cancers. Cancer Res 71: 1680-1689.
95. Lagos D, Pollara G, Henderson S, Gratrix F, Fabani M, et al. (2010) miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator. Nat Cell Biol 12: 513-519.
96. O'Hara SP, Splinter PL, Gajdos GB, Trussoni CE, Fernandez-Zapico ME, et al. (2010) NFkappaB p50-CCAAT/enhancer-binding protein beta (C/EBPbeta)-mediated transcriptional repression of microRNA let-7i following microbial infection. J Biol Chem 285: 216-225.